TSLX
Sixth Street Specialty Lending, Inc. · Financials · Asset Management
Last
$17.71
+$0.29 (+1.67%) 4:00 PM ET
After hours $17.71 −$0.00 (−0.01%) 5:04 AM ET
Prev close $17.42
Open $17.36
Day high $17.75
Day low $17.34
Volume 333,360
Avg vol 710,353
Mkt cap
$1.66B
P/E ratio
15.54
FY Revenue
$426.10M
EPS
1.14
Gross Margin
70.70%
Sector
Financials
AI report sections
TSLX
Sixth Street Specialty Lending, Inc.
TSLX combines high profitability, an elevated dividend yield, and moderate valuation multiples with slightly negative recent revenue growth and meaningful balance-sheet leverage. Price action sits in the middle of the 52-week range with multiple bullish technical signals and price holding above key moving averages, while short interest metrics and a high short volume ratio point to some positioning and sentiment risk. Overall, the data depicts a cash-generative, income-oriented lender whose shares reflect both credit-cycle exposure and technical overextension risk after recent bullish breakouts.
AI summarized at 2:33 PM ET, 2026-01-15
AI summary scores
INTRADAY: 63 SWING: 66 LONG: 69
Volume vs average
Intraday (cumulative)
−56% (Below avg)
Vol/Avg: 0.44×
RSI
55.38 (Neutral)
Neutral (40–60)
MACD momentum
Intraday
-0.00 (Weak)
MACD: -0.00 Signal: -0.00
Short-Term
+0.08 (Strong)
MACD: -0.02 Signal: -0.11
Long-Term
+0.09 (Strong)
MACD: -0.34 Signal: -0.43
Intraday trend score 63.40

Latest news

TSLX 12 articles Positive: 7 Neutral: 0 Negative: 0
Positive GlobeNewswire Inc. • Na
BridgeBio Raises $1 Billion in Preferred Equity to Accelerate Present and Upcoming Launches

BridgeBio Pharma announced a $1 billion preferred equity investment led by Sixth Street ($800M) and HealthCare Royalty ($133.9M). The Series A Cumulative Convertible Preferred Stock features a 7% dividend and conversion price of $137.79 per share (100%+ premium to 30-day VWAP). The capital strengthens BridgeBio's balance sheet as it prepares for potential launches of three blockbuster drugs: BBP-418 for LGMD2I/R9, encaleret for ADH1, and infigratinib for achondroplasia, while Attruby continues to grow as a multi-billion-dollar drug.

BBIO TSLX preferred equity investment convertible stock capital financing biopharmaceutical genetic conditions product launches
Sentiment note

Leading a major $800M investment in a commercial-stage biopharmaceutical company with multiple promising product candidates demonstrates confidence in BridgeBio's management team and pipeline potential.

Positive Benzinga • Not Specified
Figure Enters into Agreement to Acquire Kiavi, Bolstering Blockchain-Native Marketplace

Figure Technology Solutions announced a definitive agreement to acquire Kiavi, an AI-powered lending platform for residential real estate investors, for $717 million. The transaction includes a joint venture with Sixth Street to acquire Kiavi's balance sheet assets. The acquisition is expected to add $7 billion in annual first-lien volume to Figure's marketplace, advance its tokenization mission, and support Figure's 60% medium-term EBITDA margin target with accretion to earnings per share and payback in under four years.

FIGR TSLX blockchain tokenization real estate lending acquisition AI-powered platform capital marketplace
Sentiment note

Sixth Street is partnering with Figure in a joint venture to acquire Kiavi's balance sheet assets, leveraging its residential mortgage and private credit expertise. The partnership allows Sixth Street to participate in the growing blockchain-native capital markets and support a leading originator's growth.

Positive GlobeNewswire Inc. • Na
Enstar Announces Acquisition of AF Group

Enstar Group Limited, backed by Sixth Street Partners, has entered into a definitive agreement to acquire 100% of Accident Fund Holdings, Inc. from Blue Cross Blue Shield of Michigan for an undisclosed amount. AF Group, headquartered in Lansing, Michigan, generated $3.3 billion in consolidated gross written premium in 2025 and operates across all 50 states. The acquisition is expected to close in the second half of 2026 pending regulatory approvals, with AF Group operating as a standalone subsidiary under its existing leadership.

TSLX acquisition insurance reinsurance property and casualty workers compensation regulatory approval financial strength
Sentiment note

The transaction expands Sixth Street's investment footprint in the insurance sector, continuing its strategy of partnering with leading insurance companies. This demonstrates confidence in the insurance market and adds a significant asset ($3.3B premium business) to Sixth Street's portfolio of over $125B in assets under management.

Positive Investing.com • Bob Ciura
3 High Dividend BDCs With Yields Over 5%

The article discusses three Business Development Companies (BDCs) with high dividend yields over 5%, highlighting their investment strategies, financial performance, and potential attractiveness for income investors.

MAIN GAIN GAINI GAINL BDCs dividend yields income investing middle market companies
Sentiment note

Reported robust net investment income up 10.7% year-over-year, maintained consistent earnings per share, and has a diversified investment portfolio

Positive Benzinga • Globe Newswire
Sixth Street Completes Acquisition of Enstar

Sixth Street has completed its $5.1 billion acquisition of Enstar Group Limited, taking the company private at $338.00 per ordinary share. The transaction was approved by Enstar shareholders and will result in Enstar continuing operations as a privately held company.

ESGR ESGRO ESGRP TSLX acquisition private equity insurance merger
Sentiment note

Successfully completed a major acquisition of a global insurance group, expanding their investment portfolio

Positive Benzinga • Globe Newswire
Enstar Shareholders Overwhelmingly Approve Sixth Street Acquisition

Enstar Group Limited shareholders have approved the company's acquisition by Sixth Street, Liberty Strategic Capital, J.C. Flowers & Co. LLC, and other institutional investors. The transaction is expected to close in mid-2025, subject to regulatory approvals.

ESGR ESGRO ESGRP TSLX Enstar Group Limited Sixth Street Liberty Strategic Capital J.C. Flowers & Co. LLC
Sentiment note

Sixth Street is the acquiring company, and the article mentions that it is participating in the transaction along with other institutional investors.

Positive GlobeNewswire Inc. • John Romagnoli
FirstLight Fiber Raises $120 Million in Strategic Holdco Financing from Sixth Street and Palistar Capital

FirstLight Fiber, a leading fiber bandwidth infrastructure provider in the Northeast U.S., has raised $120 million in new strategic debt financing from Sixth Street and Palistar Capital. The financing will support the company's growth strategy.

TSLX FirstLight Fiber Sixth Street Palistar Capital fiber bandwidth infrastructure debt financing
Sentiment note

Sixth Street, a leading global investment firm, is described as having deep experience supporting companies across the telecommunications sector. Its participation in the financing deal with FirstLight Fiber indicates its confidence in the company's growth potential.

Unknown Seeking Alpha • Samuel Smith
Very Overrated And Very Underrated High Yield Sectors

Not all high yield subsectors are good investments all the time. Click here for the one Mr. Market is overrating and underrating, and also my top picks.

APO ARCC ARES BAM
Unknown Seeking Alpha • Scott Kennedy
Ares Capital's NAV, Valuation, And Dividend Versus 14 BDC Peers - Part 2 (Includes Dividend Projection + BXSL Coverage)

Ares Capital's dividend sustainability remains one of the highest in the sector. Check out why ARCC stock is a safe investment with decent value.

BDCX BDCZ BLK BXSL
Unknown Seeking Alpha • Gen Alpha
Buy These Smart 7-9% Yields Before The Market Wakes Up To Income

Buying stocks doesn't have to be a popularity contest. Read why Sixth Street Specialty Lending and Imperial Brands are good investment opportunities.

TSLX ARCC OBDC IMBBY
Unknown Seeking Alpha • Blue Harbinger
Ares Capital: Building A Big-Yield Portfolio (BDCs, CEFs, REITs)

Ares has a wide investment diversification generally, but also has more second-lien and fixed-rate loans than many other BDCs. Find out more on ARCC here.

AMT BBDC BXSL CCI
Unknown Seeking Alpha • Samuel Smith
Ares Capital's Q1 Has Important Ramifications For The BDC Sector

Ares Capital recently reported Q1 results. Read why ARCC stock is a hold given its quality underwriting performance, and not outlandish premium to NAV.

BIZD ARES BXSL OBDC
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal